1. Introduction {#s0005}
===============

Dystonia is a common movement disorder characterized by involuntary muscle contractions that lead to abnormal repetitive movements or postures ([@bb0010]). A large variety of clinical syndromes can be roughly divided into primary and secondary forms based on their etiology. Primary dystonia occurs in the absence of an associated disease. Secondary dystonia is defined by a known acquired etiology, such as brain injury or medication. Dystonia is also characterized based on clinical features, including a wide spectrum of segmental dystonia forms. The prevalence of primary dystonia is approximately 16.42 per 100,000 people ([@bb0535]). Cervical dystonia (CD), also called spasmodic torticollis, is the most frequent type of primary dystonia and has prevalence of 4.98 / 100,000 people in Europe ([@bb0445]; [@bb0535]). The clinical characteristics of dystonia are often described based on 5 factors: age at onset, body distribution, temporal pattern, coexistence of other movement disorders, and other neurological manifestations ([@bb0010]). CD, together with blepharospasms and writer\'s cramp, are classified as focal dystonias. Although CD is perceived as a motor disorder, neurophysiological observations have identified sensory dysfunctions, i.e., dysfunction in spatial discrimination ([@bb0370]). The geste antagoniste (sensory ticks) is often observed in patients with CD (84%) and indicates an active contribution of sensory afferent inputs to the manifestation of focal dystonia ([@bb0345]). Significant pain is also commonly associated with CD ([@bb0315]).

The clinical symptomatology of CD is well defined, but its pathophysiology remains unknown. Because various genes are involved and patients exhibit variable sensitivity to pharmaceuticals, heterogeneous pathogenic effects ([@bb0060]; [@bb0125]) are indicated.

Traditionally, dystonia was regarded as a disease of the basal ganglia (BG) ([@bb0035]; M. [@bb0195]). Clinical associations between dystonic features and other movement disorders have also suggested the involvement of the BG ([@bb0335]; [@bb0560]). In the standard model of the functional connections between basal ganglia nuclei, the thalamus, and the cortex, a direct pathway mainly facilitates activity in the motor cortex and the indirect pathway inhibits movements ([@bb0015]; [@bb0095]; [@bb0155]). The center-surround model of basal ganglia function extends this model and consequently allows its application to hypo- and hyperkinetic movement disorders by introducing the concept of a parallel enhancement of the desired movements and inhibition of unwanted movements ([@bb0360]). Although this model is incomplete, it is suitable for approximating the pathophysiology of CD ([@bb0150]). [Fig. 1](#f0005){ref-type="fig"} provides a schematic overview of the known connections and loops relevant to basal ganglia motor function. Furthermore, neuropsychological studies have reported that sensory systems are involved in CD by demonstrating abnormal sensory processing ([@bb0370]; [@bb0550]; [@bb0025]).Fig. 1Schematic representation of botox treatment (BNT) in basalganglia network.The well characterized basal-ganglia loops, thalamo-cortical and cerebellar-thalamic loops are illustrated. In particular the main routes of the striato-fugal connections are displayed: the direct pathway with D2R-expressing striatal MSNs innervating the GPe and the indirect pathway with D1R-expressing striatal MSNs projecting to the GPi and STN. Abbreviations: Btx - Botoliumtoxin, C - caudate ncl, D1R -- dopamin receptor 1, D2R -- dopamine receptor 2, GPi - internal pallidum, Gpe - external pallidum, M - primary cortex, MSN - medium spiny neurons, STN - subthalamic ncl, PoCb - pontocerebellum, P - putamen, S1/2 - primary and secondary somatosensory cortex, SNC - substantia nigra pars compacta, SpCB - spinocerebellum, T - thalamus, dashed red lines: mainly inhibition connection, dashed blue lines: activating connection, dashed orange lines: dopaminergic innervation. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 1

A growing number of imaging studies using positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) have aimed to explore the underlying cerebral changes in patients with CD. The authors have shown widespread changes in brain activity and malfunctions in the brainstem, cortical and subcortical structures ([@bb0035]; [@bb0060]; [@bb0405]). Several lines of electrophysical evidence support the hypothesis that a loss of inhibition occurs in several parts of the motor and sensory systems ([@bb0540]; [@bb0020]; [@bb0355]; [@bb0195]). Recently, a fMRI study revealed a loss of inhibition and resulting brain overactivation in multiple brain areas (i.e., the cingulate cortex and primary and secondary somatosensory cortices) following kinesthetic sensory stimulation in patients with CD ([@bb0420]). Currently, CD is regarded as a cerebral network disease ([@bb0090]; [@bb0235]; [@bb0240]; [@bb0450]) with a brain-wide loss of inhibition and increased neuroplasticity ([@bb0200]).

Currently, botulinum neurotoxin (BNT) has been shown to be an effective treatment for the motor and non-motor symptoms of CD ([@bb0570]; [@bb0225]; [@bb0085]). A recent Cochrane review analyzed data from 8 RCTs (double-blind, parallel, randomized, placebo-controlled trials) that investigated the application of BNT in patients with CD ([@bb0065]). The BNT treatment reduced the CD severity, disability, and pain; compared to the placebo, its application is well tolerated, and typical adverse events include dysphagia and diffuse weakness. In principle, therapy with BNT exerts inhibitory actions on muscle contraction by blocking acetylcholine-mediated transmission at the neuromuscular junction ([@bb0210]), leading to relaxation of the affected muscle. Based on considerable evidence, BNT may also influence the central nervous system at the spinal and cerebral levels ([@bb0170]; [@bb0205]). Consequently, the treatment of dystonic muscles with botulinum toxin (BNT) may cause changes at multiple levels of the sensorimotor system, from transmission at the neuromuscular junction to the cerebral cortex ([@bb0005]; [@bb0250]; [@bb0600]).

Although key regions that are potentially associated with CD pathophysiology have been identified, further studies are needed to understand how their deviation from normal physiological brain function and communication should be classified. We had two main objectives in the present study. We aimed to do the following: (1) identify which brain regions are involved in CD and how changes in these regions lead to abnormal brain network function, and eventually (2) evaluate the effect of a BNT treatment. Here, we hypothesized that the treatment of patients with CD with BNT would also affect patterns of brain activity and partially restore normal brain function by decreasing the output of the motor cortex towards the affected muscles. Thus, changes in brain function and network activity in patients with CD are potentially related to the underlying cause, to compensatory efforts or, most likely, to a combination of the two; one might argue that BNT treatment possibly helps to unmask causes from effects on patients with CD. Brain function was assessed using 3.0 T functional magnetic resonance imaging (fMRI). We applied functional and effective connectivity analyses to quantify changes in brain and network activity in patients with CD and the effect of the BNT treatment. We employed a regional homogeneity analysis to measure the degree of synchronicity of brain activity in specific structures ([@bb0605]).

2. Methods {#s0010}
==========

2.1. Subjects and treatment with BNT {#s0015}
------------------------------------

The study was approved by the local ethics committee, and all subjects gave their written informed consent according to the Declaration of Helsinki. The study is registered within the German Clinical Trials Register (DRKS0003696).

We studied 17 patients with a clinically confirmed diagnosis of primary CD (9 females, age 61.3 ± 8.3 years) (initially we investigated 19 patients, 2 were excluded due to severe head motion artifacts in the MR scans). All patients had pure neck involvement (10 left- and 7 right-sided torticollis deviation, disease duration 11.6 ± 5.15 years) and were naive to treatment with BNT at the time of the first fMRI. The severity of CD was assessed with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). After 6 months of treatment of the dystonic neck muscles with BNT-A (in total 3 applications), a second fMRI examination followed by a clinical evaluation took place. Supplemental Fig. S4 provides a schematic overview of the timelines of BNT application and MRI acquisition.

Healthy age- and sex-matched controls (*N* = 17, 8 females, age 63.5 ± 10.5 years) were given a routine examination by an expert neurologist, which revealed the absence of any present clinical manifestations of neurologic or psychiatric diseases. The demographic and clinical data are shown in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}.Table 1Study participants: controls and patients with CD.Table 1controlsPatients with CDAge (yrs)/genderHandednessMMSEAge (yrs)/genderHandednessMMSEDisease duration (yrs)134/MR3054/FL303255/MR3048/ML3018356/MR3047/MR3013456/MR3068/FR2921558/FR3065/MR309661/FL3068/FR296761/MR3067/FR2811863/FR3067/FR3016963/ML3066/FR3071068/FR3060/MR30151170/FR3070/FR28171270/FR3062/MR30121371/FR3045/MR3081471/MR2870/MR3091573/MR2955/FR2941674/FR3066/MR30131775/MR3064/FR3016Mean ± std63.5 ± 10.5, 8 F/9 M15 R/2 L61.3 ± 8.3,9 F/8 M15 R/2 L11.6 ± 5.15[^1]Table 2Patients with CD - disease duration and clinical degree of severity before and after BNT application.Table 2Age (yrs)/genderDisease duration (yrs)TWSTRS (naive)TWSTRS (BNT)Last treatment/duration145/M82716100 Xeomin/6 months247/M132115100 Xeomin/6 months348/M18179105 Botox/6 months454/F32316150 Xeomin/6 months555/F4227100 Xeomin/6 months660/M152014300 Dysport/6 months762/M12201080 Xeomin/6 months864/F161813150 Xeomin/6 months965/M9227150 Xeomin/6 months1066/F72316100 Botox/6 months1166/M132215120 Xeomin/6 months1267/F11171080 Botox/6 months1367/F162113100 Xeomin/6 months1468/F212820105 Xeomin/6 months1568/F63927100 Botox/6 months1670/F172618300 Dysport/6 months1770/M92811150 Xeomin/6 monthsMean ± std61.3 ± 8.3, 9F/8 M11.6 ± 5.1523 ± 5.314 ± 5.0[^2]

### 2.1.1. Functional magnetic resonance imaging recordings {#s0020}

All experiments were performed on a 3 T MR scanner (Trio, Siemens, Erlangen, Germany) to obtain echo-planar T2\*-weighted image volumes (EPI) and transaxial T1-weighted structural images. The EPI images (voxel size = 3 mm × 3 mm × 3 mm; repetition time = 2.52 s; TE = 35 ms; 40 transaxial slices; 740 images in total) covered the entire cerebrum and cerebellum. Functional data were acquired in two EPI sessions with 203 (resting-state fMRI) and 403 (event design with stimulation of the right hand) images. The high-resolution T1-weighted structural images had a voxel size of 1 mm × 1 mm × 1 mm to allow precise anatomical localization.

### 2.1.2. Resting-state fMRI (rs-fMRI) {#s0025}

For the recording of the rs-fMRI, participants were instructed to lie still and keep their eyes closed for the whole recording (203 images, approx. 8.5 min).

### 2.1.3. Event design fMRI {#s0030}

While lying in the fMR scanner, subjects were stimulated by an air-driven pneumatic device (air-puff). Stimuli were applied to the index finger of the right and left hand in a pseudorandomized order (403 images, approximately 17 min, stimuli duration 2 s, interstimulus interval ranged between 20 and 30 s, 20 stimuli to the left and 20 to the right hand separately). A similar fMRI paradigm was employed in our previous studies ([@bb0040]; [@bb0045]; [@bb0295]).

2.2. Data analysis {#s0035}
------------------

Data analysis was performed using MATLAB 2015b (Mathworks, Natick, MA) and SPM12 software (Wellcome Department of Cognitive Neurology, London, UK, <http://www.fil.ion.ucl.ac.uk/spm>). Standard preprocessing included rejection of the first 3 images, realignment ([@bb0275]) and normalization to the Montreal Neurological Institute (MNI) standard brain (Evans et al., n.d.), and smoothing with a 6-mm full-width-at-half-maximum Gaussian kernel. For temporal filtering and denoising of rs-fMRI data, we employed the methods provided in the REST toolbox for MATLAB ([@bb0530]).

2.3. Motion artifacts {#s0040}
---------------------

Involuntary head movements are a key feature of patients with CD. Therefore, the mounting apparatus in the MR scanner included a firm foam padding around the head and restraining straps across the chin. We calculated the maximum motion using the first three parameters of the rigid body correction to quantify the head motion in the MRI data: maximum movement = $\sqrt{x^{2} + y^{2} + z^{2}}$ in mm). A detailed description of the measurement of head motion and its influence on rs-fMRI data is provided in the study by [@bb0585]. In recent studies, relative movements of \> 0.1 mm are considered micro movements and \> 0.55 mm as gross movements ([@bb0475]; Van et al. 2012). In our study, we counted the micro movements, and subjects with interscan movements \> 0.4 mm were excluded (we excluded 2 patients with CD prior to data analysis according to this criterion, and these subjects are not included in the present study). Supplementary Figs. 1 and 2 show the results of the head motion analysis.

2.4. Defining regions of interest (ROI) {#s0045}
---------------------------------------

As shown in [Fig. 1](#f0005){ref-type="fig"}, pathophysiology and recent literature suggest the involvement of the somatosensory and motor cortices, the basal ganglia, and the thalamus in the manifestation of CD. Accordingly, we defined the following ROIs: primary motor cortex (M1), primary and secondary somatosensory cortices (S1/S2), thalamus, subthalamic nucleus, putamen, pallidum, and caudate nucleus. The selected brain regions and representative MNI coordinates are shown in [Table 3](#t0015){ref-type="table"}.Table 3Definition of regions of interest (ROIs).Table 3Size in voxelsXYZ (MNI coordinates)LeftRightM1 (primary motor cortex)324−40 −29 5936 25 56S1 (primary somatosensory cortex)486−52 −29 5644 --29 56S2 (secondary somatosensory cortex)162−41 20 1347 --23 14Putamen485−24 4 426 3 4Pallidum162−20 −6 −115 --4 −1Caudate ncl.385−16 4 1413 5 14Thalamus324−16 −23 −414 −21 −4Subthalamic ncl.38−3 −20 −128 −18 −12Occipital cortex500−24 −94 832 −91 8[^3]

We applied two different strategies for the definition of the regions of interest (ROIs) for the following analysis. First, we manually defined the BG and the thalamus in each individual coregistered T1 image and stored the ROIs in NIFI-file format. Then, the ROIs were normalized using the transformation matrix of the normalized T1 image, and a mean ROI was created by averaging all individually mapped ROI images (thresholded above 0.5). For the definition of the somatosensory and the motor cortex, we performed a general linear model (GLM) analysis of the event design fMRI images, as implemented in SPM software. Second-level results were thresholded and corrected for multiple comparisons at *P* ≤ 0.01 FWE. Significantly activated regions within the left and right hemispheres were assigned according to the SPM toolbox Anatomy ([@bb0120]). Supplementary Fig. 3 shows the brain regions that were activated by the stimulation of the left hand.

The occipital cortex was included for the regional homogeneity analysis and was composed of 500 randomly chosen voxels of V1-3 from the anatomy toolbox. We chose the occipital cortex as the area for validation because, to date, there is no valid evidence that the occipital region is critical for CD pathophysiology.

2.5. Connectivity and regional homogeneity (ReHo) analysis {#s0050}
----------------------------------------------------------

Several sources of variance were removed from the data using linear regression: (1) six parameters obtained by rigid body correction of head motion, (2) signal from a ventricular region of interest, (3) signal from a region centered in the white matter, and (4) mean global signal of the whole brain. All signal intensity time courses were bandpass filtered (0.01 \< f \< 0.1 Hz) to reduce the effects of low-frequency drift and high-frequency noise.

Within each region, each voxels\' time series were extracted. For the functional and effective connectivity analysis, average time courses for each ROI were estimated by averaging the time series of all voxels within an ROI.

### 2.5.1. Functional connectivity {#s0055}

Changes in the functional connectivity between ROI-specific time series were measured by calculating Pearson correlation coefficients. R-values were transformed to z-values by the Fisher r-z transformation. Findings were considered significant at *p* ≤ 0.05 (2-sample *t*-test for independent or dependent samples, corrected for multiple comparisons using a Bonferroni/FWE-correction).

### 2.5.2. Effective connectivity {#s0060}

Conditional Granger causality analysis is an approach used to explore the dynamic causal relationships between time series ([@bb0175]) and has been used in several fMRI studies ([@bb0165]; [@bb0465]; [@bb0580]). In this study, Conditional Granger causality was performed using the toolbox implemented by Seth ([@bb0500]). Findings were considered significant at *p* ≤ 0.01 (2-sample t-test for independent or rather dependent samples, corrected for multiple comparisons using a Bonferroni/FWE-correction). A more detailed description of functional and effective connectivity analyses is given in our previous work ([@bb0050])

### 2.5.3. Regional homogeneity (ReHo) {#s0065}

To evaluate the synchronicity within a brain region, we applied a voxel-based measure (Kendall\'s coefficient of concordance, KCC) to quantify the similarity of a voxel and its 26 surrounding neighbors in a time series. KCC values can range from 0 to 1, where higher values indicate a greater similarity between the activation pattern of a specific voxel and its surrounding neighbors ([@bb0605]). For each brain region, KCC values were averaged and compared between groups of healthy and CD subjects. Findings were considered significant at p ≤ 0.01 (2-sample t-test for independent or dependent samples, corrected for multiple comparisons using a Bonferroni correction).

3. Results {#s0070}
==========

First, we examined changes in the local brain and network activity in patients with CD prior to treatment with BNT in comparison to brain function in healthy controls.

3.1. Changes of local brain and network activity in cervical dystonia {#s0075}
---------------------------------------------------------------------

### 3.1.1. Functional connectivity {#s0080}

To detect changes in the sensorimotor and basal ganglia network, we performed functional connectivity analysis between members of this network as well as substructures of the basal ganglia and the thalamus. For a more detailed description of these seed regions see [Table 3](#t0015){ref-type="table"}.

Functional connectivity can quantify the connections between these brain regions based on time-coursed correlations, because normal brain activity is realized by a group of synchronized neurons ([@bb0590]).

Compared to CD, in controls ([Fig. 2](#f0010){ref-type="fig"}, left / green; Supplementary Table 1), we found increased communication within the primary (S1) and secondary (S2) somatosensory cortex. In contrast, the CD group ([Fig. 2](#f0010){ref-type="fig"}, left / red; Supplementary Table 1) yielded increased information flow within the basal ganglia and between the basal ganglia and the thalamus, as well as between the somatosensory cortex and the motor cortex. The thalamus was highly connected to the putamen, the caudate body, and the subthalamic nucleus.Fig. 2Results from the functional (A) and effective (B) connectivity analyses of patients with cervical dystonia (CD) and the effects of treatment with botulinum toxin (BNT).Schematic representation of (A) functional connectivity (FC) and (B) Granger causality (GC) in resting-state fMRI from (left panels) the controls compared with the patients with CD (naive to treatment with BNT) and (right panels) the patients with CD who were treated without (naive) and with BNT (6 months). The results for the comparisons between patients with CD and controls (independent samples) and between patients with CD before and after BNT treatment (dependent samples) were corrected for multiple comparisons using a Bonferroni/FWE correction. In the figure, the lines indicate increased connectivity between specific brain regions; in GC, the direction of the arrow indicates the direction of the effective connectivity. A / left panel: in controls, FC between S1/S2 is increased; in patients with CD, increased connectivity within the BG, the thalamus, the motor cortex, and S2 is observed. A / right panel: the connectivity between S1/S2 is increased in patients with CD following BNT treatment; before the BNT application, the FC between the putamen and the thalamus, the STN, and the motor cortex is increased. B / left panel: in patients with CD, increased coupling of the putamen towards the pallidum and S2, S2 towards the motor cortex, and STN towards the thalamus is observed; increased autonomy in the pallidum and the thalamus is also detected. B / right panel: increased coupling of the motor cortex towards the caudate nucleus is observed in patients with CD following the BNT application; before the BNT application, increased GC exists between the putamen and the thalamus towards S2 and increased autonomy of the STN.Fig. 2

### 3.1.2. Identifying changed network dynamics with predictive causality network analysis--Granger causality {#s0085}

To further identify the driving force behind the above mentioned changes in the information flow within the somatosensory and basal ganglia network, we applied Granger causality analysis. While Granger causality can reveal the direction of the information transfer within a time series, a rising Granger autonomy is a measure to uncover increasing independence of a time series from other sources ([@bb0500]).

Compared to the CD patients, there was no significant increased directed information flow within the sensorimotor network in the control group ([Fig. 2](#f0010){ref-type="fig"}, left/green; Supplementary Table 1). Although in CD, effective connectivity as measured by Granger causality was increased in all subunits of the sensorimotor network ([Fig. 2](#f0010){ref-type="fig"}, left/red; Supplementary Table 1). We discovered most changes within the putamen which directly influenced the information flow within the pallidum and S2. Additionally, the putamen was stripped of other influencing and controlling sources as indicated by the increase in Granger autonomy. Increases in the Granger autonomy were also found within S1 and the thalamus. Furthermore, the effective connectivity was increased from S2 towards the primary motor cortex and from the subthalamic nucleus towards the thalamus.

In summary, in the CD patients, the putamen, the thalamus, and S1 became less modifiable and more independent from other brain regions. In particular, the putamen increasingly influenced information processing within the whole sensorimotor network.

### 3.1.3. Regional homogeneity (ReHo) {#s0090}

A method to evaluate the synchronicity within brain regions is regional homogeneity (ReHo)([@bb0605]). By calculating Kendall\'s coefficient of concordance (KCC) of each voxel and its nearest neighbors within a specific brain region, an index of signal similarity is achieved. As stated by [@bb0230], the ReHo across large brain areas might differ largely. We therefore used the ROIs as described in [Table 3](#t0015){ref-type="table"} and limited the voxel count to a maximum of 500 voxels ([@bb0230]).

The average KCC was significantly increased in the CD patients within the primary motor cortex, S1, the putamen and the thalamus (independent sample *t*-tests at *p* ≤ 0.01) ([Fig. 3](#f0015){ref-type="fig"}, green vs. red; Supplemental Table 3). No significant increase in KCC was found in the healthy controls.Fig. 3Regional homogeneity analysis in cervical dystonia (CD) and effects of treatment with botulinum toxin (BNT).Kendall\'s coefficient of concordance (KCC) and standard error of the mean of the defined ROIs in the primary motor cortex (M1), the primary and secondary somatosensory cortex (S1 / S2), the BG, and the thalamus in the controls and the CD patients without (naive) and with BNT (6 month) treatment. In CD (naive) KCC values were significantly increased (*p* ≤ 0.01, 2-samples *t*-test: red vs. green) in M1, S1, putamen, and thalamus (compared to healthy controls). With BNT treatment KCC values in CD were again significantly decreased (p ≤ 0.01, paired t-test: blue vs. red) in S1 and putamen. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 3

3.2. Effect of BNT treatment on the altered brain and network activity in CD {#s0095}
----------------------------------------------------------------------------

All patients with CD were treated three times with BNT-A at months 0, 3, and 6. Two weeks after the last BNT injection, the second fMRI examination was performed (please refer to Fig. S4 for more details). According to a decrease in the TWSTRS score, all CD patients experienced an improvement of dystonic symptoms at the time point of the second fMRI (day 0 mean TWSTRS score was 23 ± 5.3; day 180 mean TWSTRS score was 14 ± 5.0) (clinical details in [Table 2](#t0010){ref-type="table"}).

Based on the aforementioned changes in brain activity, we compared the functional and effective connectivity, as well as the ReHo, in the CD patients before and after BNT treatment (2-sample t-test for dependent samples). No correlations were found between connectivity changes and the effect of clinical treatment (TWSTRS scores).

After correction for multiple comparisons, there were no significant connectivity changes in the group comparison at both time points (control vs. CD (naive to treatment) and control vs. CD (following BNT treatment)).

### 3.2.1. Functional connectivity (FC) {#s0100}

FC analysis revealed two main effects of BNT treatment in CD. Following BNT treatment, the communication between S1 and S2 increased ([Fig. 2](#f0010){ref-type="fig"}, right/blue; Supplementary Table 2). Furthermore, connectivity within the basal ganglia and between the basal ganglia, the thalamus and the sensorimotor cortex decreased ([Fig. 2](#f0010){ref-type="fig"}, right/red; Supplementary Table 2).

Comparing the changes on both sides of [Fig. 1](#f0005){ref-type="fig"}, multiple matches can be found. This indicates a partial convergence of connectivity patterns between the controls and the BNT-treated CD patients.

### 3.2.2. Identifying changed network dynamics with predictive causality network analysis -- Granger causality {#s0105}

After BNT treatment, several changes in the effective connectivity between the sensorimotor network and the basal ganglia were observed ([Fig. 2](#f0010){ref-type="fig"}, right; Supplementary Table 2). First, the influence of the thalamus and the putamen on the somatosensory cortex was reduced. Second, the input to the striatum via the motor cortex increased. Finally, the autonomy of the subthalamic nucleus decreased.

### 3.2.3. Regional homogeneity (ReHo) {#s0110}

There were 4 brain regions with increased KCC values in CD: the primary motor cortex, S1, the putamen and the thalamus. Treatment with BNT reduced KCC values in the putamen and S1 ([Fig. 3](#f0015){ref-type="fig"}; Supplementary Table 3). However, there were no significant changes in the thalamus and the motor cortex.

For all group comparisons (FC, GC, and ReHo), we performed a two-way ANOVA with disease duration and severity (TWSTRS) as independent factors; no significant interactions were identified.

4. Discussion {#s0115}
=============

In the current study, we identified two striking distinctive features in CD. First, there was increased connectivity within the basal ganglia and between the basal ganglia, the thalamus and the sensorimotor cortex. The most connections were derived from the putamen and the thalamus. Some of these key regions, namely, the putamen, the thalamus and the somatosensory cortex, became less responsive to other potential regulating inputs. Second, our data suggested an impaired integration of higher somatosensory functions in CD.

Our data support that CD is a functional network disease ([@bb0035]). A deficient integration between the basal ganglia (i.e., putamen) and somatosensory cortex seemed to play a pivotal role in sustaining abnormal brain activity in CD.

With clinical improvement after BNT treatment, some of these changes in brain activity declined. Connectivity originating from the BG and especially from the putamen decreased, and communication within the somatosensory cortex improved. In the following subsections, these key findings will be discussed in more detail.

4.1. Basal ganglia function {#s0120}
---------------------------

In the basal ganglia, different parallel information pathways exist. These pathways include several common input (i.e., the striatum) and output (i.e., the globus pallidus internus (GPi) and thalamus) structures, as well as exclusive structures such as the subthalamic nucleus (STN) and the globus pallidus externus (GPE) ([@bb0015]; [@bb0095]). Moreover, there are both excitatory (mainly glutamatergic) and inhibitory (mainly GABAergic) connections ([@bb0305]; [@bb0395]; [@bb0575]). Dopaminergic input from the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA), for instance, can result in both inhibition and excitation of striatal projection neurons (so-called medium spiny neurons within the striatum) ([@bb0155]; [@bb0485], [@bb0490]). Accordingly, high and low dopamine levels in the striatum can cause dystonic symptoms ([@bb0035]; [@bb0595]). Another main glutamatergic excitatory input to the BG via the striatum comes from cortical regions ([@bb0265], [@bb0270]) and the thalamus ([@bb0515]; [@bb0520]). Depending on the inhibitory (GABAergic) input from the GPi, the overall output of the thalamus towards the cortex (especially the supplementary motor cortex) can facilitate movements (as part of the so-called direct pathway) or inhibit movements (part of the indirect pathway) ([@bb0155]; [@bb0575]). In regard to the increased motor activity that is pathognomonic for CD, the observed increase in connectivity of the basal ganglia in our study is most likely associated with an increased involvement of the direct striatal pathway. Our findings are supported by increased striatal D1 receptors in dystonia, which might be an underlying cause of the increased excitatory striatal output ([@bb0510]). The increased connectivity between the motor cortex and the STN, as observed in our study, might reflect a hyperdirect cortical-subcortical input to activate the indirect striatal pathway and achieve a compensatory thalamic inhibition ([@bb0220]; [@bb0415]).

4.2. Loss of inhibition {#s0125}
-----------------------

We provide further evidence that the putamen, as the main input structure of the basal ganglia, was increasingly connected to cortical areas, the thalamus and to other basal ganglia structures in CD ([@bb0305]; [@bb0310]). We assume that this increased connectivity was associated with the flawed inhibitory control and increase in excitatory influences on the basal ganglia and cortical level ([@bb0030]; [@bb0440]). While there is increased information flow from the putamen towards the main output structure (thalamus), our analysis showed that both regions became less responsive to regulating influences in CD. In particular, the putaminal input from the cortex and the substantia nigra is less likely to be integrated. For the thalamus, regulating corticothalamic connections as well as the influence of the indirect striatal-thalamic pathway are diminished ([@bb0305]). For CD, different manifestations of loss of inhibition, ranging from short to long intracortical inhibitory dysfunctions, have been described (M. [@bb0195]; [@bb0480]; [@bb0525]). The loss of inhibition affected motor and sensory functions as well as brain stem reflexes ([@bb0035]; [@bb0360]; [@bb0525]). Our study extended this knowledge and indicated that by diminishing the regulatory and inhibitory basal ganglia output to the motor cortex, the cortical activation of desired and undesired movements became blurred in CD ([@bb0360]; [@bb0525]). This was also supported by our findings of increased synchronicity within the sensorimotor cortex, suggesting that local inhibition was disrupted.

Analysis of the regional homogeneity of brain activity has been previously used to analyze brain function ([@bb0330]; [@bb0410]). While higher degrees of synchronicity can be associated with task-specific brain activity and better performance in healthy controls ([@bb0180]; [@bb0605]), variations in cortical ReHo can also be discussed as a deficit in intracortical inhibition ([@bb0330]). An indisputable argument for the latter is that intracortical inhibition is also energy consuming and therefore linked to fluctuations of the BOLD signal ([@bb0260]).

4.3. Effects of BNT {#s0130}
-------------------

BNT has been shown to improve muscle function and pain in dystonia without any sign of muscular weakness ([@bb0075]; [@bb0570]). However, its effect is not restricted to the block of the release of acetylcholine ([@bb0210]). BNT can also affect both alpha and gamma motor neurons, selectively weaken highly active muscles, and affect muscle spindles, thereby indirectly reducing the excitability of motoneurons ([@bb0140]; [@bb0565]). BNT exhibits, to some degree, a retrograde transport into the central nervous system, at least to the level of Renshaw cells ([@bb0460]). Although transcranial magnetic stimulation suggested that BNT may affect the brain directly ([@bb0055]), it is most likely that the central effects of BNT are explained by cortical plasticity following an altered cortical representation of the affected muscles and limbs ([@bb0055]; [@bb0160]; M. [@bb0190]; [@bb0205]).

As our study shows, a main effect of BNT treatment was the reduction of connectivity between the putamen, the sensorimotor cortex, the thalamus and the STN. The synchronous activation of the putamen, thalamus and motor cortex in CD was most likely an indication of the hyperactive direct striatal-thalamic-cortical pathway that is regulated by the neuroplasticity-inducing effects of BNT treatment ([@bb0015]; [@bb0095]; [@bb0360]). By weakening dystonic muscles, BNT created a sensory-motor discrepancy and influenced the motor output of the brain. A similar principle has been debated regarding facial palsy ([@bb0290]). Most likely, the brain could not differentiate whether the motor output or the sensory input was the cause of the prediction error. Essentially high-order processing of somatosensory information within S2 is necessary for the detection of the mismatch between perceived and expected movements ([@bb0375]; [@bb0495]; [@bb0505]). Analogous to facial palsy, the altered sensory-motor feedback in the CD brain after BNT treatment was associated with a decreased connectivity within the sensorimotor network ([@bb0285]; [@bb0290]). This mechanism potentially affects the overactive excitatory connections that underlie the pathomechanisms of CD to a larger extent than the moderate inhibitory connections. An observation that conceivably supports this assumption was the altered function and increased responsiveness of the STN following BNT application ([Fig. 3](#f0015){ref-type="fig"}). As part of the indirect striatothalamic pathway ([@bb0015]; [@bb0095]), this led to enhanced cortical inhibition as measured by a decrease in local brain synchronization ([Fig. 3](#f0015){ref-type="fig"}). Conveniently for this interpretation, the CD patients with BNT treatment expressed lower levels of basal ganglia activation in a finger tapping task ([@bb0400]; [@bb0425]).

4.4. Sensorimotor integration {#s0135}
-----------------------------

A disturbed sensorimotor integration has been a common object of discussion in dystonia ([@bb0195]). Although CD is primarily a movement disorder, there are many subclinical sensory dysfunctions and sensory tricks, such as the geste antagoniste, that can relieve dystonic postures ([@bb0185]; [@bb0325]; [@bb0385]) and inflict involved as well as noninvolved limbs or body parts ([@bb0025]; [@bb0370]). Changes in task-induced activity within the somatosensory cortex have been reported to be less prominent or even absent in CD ([@bb0080]; [@bb0105]; [@bb0355]; [@bb0545]). Our data showed that communication within the somatosensory cortex was altered in CD. Compared to the healthy controls, the CD patients had a significantly reduced information transfer between S1 and S2, while S1 became less responsive to signals derived from the sensorimotor network, the thalamus and the basal ganglia. Furthermore, the directed information flow from S2 towards the motor cortex was increased. Notably, treatment with BNT improved the communication between S1 and S2. After BNT treatment, the thalamic-cortical influences upon S2 were decreased. In CD, deficient somatosensory processing may lead to distorted and aberrant sensorimotor integration, which then triggers motor function abnormalities such as coactivation of agonistic and antagonistic muscles ([@bb0005]). In some forms of focal dystonia, there is a clear association between high sensory stimulation and the repetition of a specific motor task; in blepharospasm, for instance, the sensation of a dry eye leads to escalating eye blinking ([@bb0455]). However, it is difficult to differentiate whether improper sensorimotor integration is a trigger for dystonia or a consequence. We hypothesize that CD affects the levels of somatosensory processing to a differential degree. In particular, higher levels of processing with S2 are compromised. These assumptions are supported by previous electrophysiological and neuroimaging studies that demonstrated most pronounced deficits in the spatial and temporal processing of somatosensory stimuli ([@bb0020]; [@bb0280]; [@bb0370]). An MEG study in focal hand dystonia likewise demonstrated a decreased functional connectivity within the somatosensory cortex ([@bb0070]; [@bb0425]).

By reducing the effective movement through BNT application, the load of sensorimotor integration is globally reduced. Consequently, there remain less distorted and aberrant signals leading to inappropriate motor program activation and basal ganglia input which again reduces potential prediction errors ([@bb0145]; [@bb0320]). The effects of BNT on the sensorimotor network and a partial normalization of brain function have been reported previously ([@bb0090]; [@bb0400]; [@bb0425]; [@bb0430]); here, we want to emphasize again that the effects of BNT are an indirect cause of cortical plasticity most likely induced by alterations in sensorimotor integration ([@bb0300]). Therefore, partially diverging effects are to be expected, and to fully cover and systemize these effects, much larger groups of patients and subtypes of dystonia need to be observed in the future.

4.5. Multiple causes for CD manifestation (concept of a second hit) {#s0140}
-------------------------------------------------------------------

Findings in monogenetic dystonia syndromes (\>14 genes have been identified to date) have suggested that there is often more than one additional environmental factor necessary to develop dystonia symptoms ([@bb0035]). These extrinsic factors in the form of a "second hit" can include injury, viral infections, and emotional or physical stress ([@bb0115]; [@bb0470]) These observations, however, make it plausible that there are also multiple intrinsic alterations that lead to the onset of dystonia. Accordingly, the combination of GABA inhibitory deficits, especially within the basal ganglia, accompanied by impaired sensorimotor integration, might be essential for the breakthrough of dystonic symptoms.

4.6. Study limitations {#s0145}
----------------------

We acknowledge several limitations of the study that temper our conclusions and should be addressed in future research. Although there is some evidence for the involvement of other brain regions in CD ([@bb0090]; [@bb0110]; [@bb0240]), we restricted the number of analyzed brain regions to a set relevant to our working hypotheses. As illustrated in [Fig. 1](#f0005){ref-type="fig"}, we were mainly interested in brain regions that are known to be involved in the pathophysiology of CD: the motor cortex, basal ganglia, thalamus loop and the somatosensory integration. Due to technical reasons, we did not differentiate between GPi and GPe. Although differential extraction and time series analysis of GPi and GPe is feasible ([@bb0340]), in our preprocessing process \<20 voxels for each GPi survived; therefore we extracted the globus pallidus as a whole.

In general, a clinically prominent lateralization of the involved neck muscles is observed in patients with CD. Debate exists regarding the presence of a corresponding lateralization of abnormal brain function. Higher sensory functions have consistently been reported to be impaired bilaterally ([@bb0370]); similar impairments in brainstem reflexes have been reported in patients with CD ([@bb0380]). Recent MEP and SEP studies only found abnormal surround inhibition in the hemisphere contralateral to the affected body part; median nerve stimulation, for instance, revealed a lateralization of the precentral P22/N30 components to the contralateral hemisphere, when the splenius capitis muscle was involved, and to the ipsilateral hemisphere, when the sternocleidomastoid muscle was involved ([@bb0255]; [@bb0245])([@bb0350]). Asymmetric BG output has also been described in patients with CD ([@bb0365]). In the present study, we did not differentiate the left and right hemispheres. All ROIs were selected from the right and left sides of the brain in a balanced manner because we intended to study global changes in brain function in patients with CD.

A further issue of debate is the method of fMRI data acquisition itself. Image sampling below 1 Hz, as is common in fMRI, is not able to model fast signal fluctuations that are observed within the somatosensory network and the basal ganglia ([@bb0070]). In addition to the "rate model" to explain basal ganglia function, there have been plenty of reports that the temporal patterns of activity in the basal ganglia circuits is of importance in normal motor function as well as in dystonia (M. [@bb0100]; [@bb0150]; [@bb0395]). To further address this matter, combined fMRI and MEG studies must be performed. Further limitations include the known alterations of autonomic functions caused by the application of BNT ([@bb0555]). Although the potential impacts on blood pressure, the heart, and the respiratory rate might affect the fMRI signal ([@bb0215]), the overall known effect of BNT A application in CT appears to be minor ([@bb0390]). However, we must not completely neglect the influence of BNT on autonomic functions; thus, we did not administer BNT to our control group. Additionally, an analysis of head motion in our fMRI data revealed significant differences between controls and patients with CD (Supplemental Figs. 1 and 2). Signal changes in MR data caused by head motion can affect measures of a connectivity analysis (i.e., decreased coupling of distributed networks and increased coupling in local networks) ([@bb0585]; [@bb0475]). As shown in a recent study by [@bb0435], the type of motion correction used in our preprocessing pipeline, including the regression of all 6 head motion parameters (provided by the rigid body correction), the average time series signal from the white matter and the cerebral spinal fluid (CSF) and the global signal, provides adequate control of motion artifacts; however, no currently available method provides perfect motion compensation.

Another aspect that should be discussed is the time intervals at which BNT is applied and the timing of the pre- and post fMRI scans. The time intervals of ≥ 12 weeks are consistent with clinical standards ([@bb0065]; [@bb0135]). In our study, we re-assessed the clinical data obtained two weeks after every BNT application. Based on these validation experiments, we adjusted the dose and localization of the BNT application in the next session. In our general clinical experience, after 2--3 BNT applications, we achieve good and reproductive outcomes. However, since many recent studies that investigated the effect of BNT on brain activity used fewer BNT applications, different outcomes are conceivable.

The underlying pathophysiological mechanisms in primary dystonias clearly extend beyond the pure motor network. The hallmarks of CD are an impaired neurotransmitter system (i.e., GABA-mediated inhibition), changes in basal ganglia connectivity and a malfunction or an imbalance of higher somatosensory integration and sensorimotor pathways. Therefore, to fully uncover its causes, research on a cellular and global network level must be carried out and combined. Understanding how dystonia, which is both a single receptor and a system-wide disease, develops will not only help to improve and monitor treatment but also to deepen our understanding of fundamental neural mechanisms related to motor learning and sensorimotor integration.

5. Conclusion {#s0150}
=============

Alterations in local brain function and connectivity in CD are characterized by increased connectivity within the basal ganglia and the sensorimotor network as well as a loss of responsiveness in key regions, such as the putamen, the thalamus, and the somatosensory cortex. Unarguably, the cause and effect of CD cannot be dissociated from these results alone. However, by monitoring the effect of an effective treatment that only interferes with the direct output of the motor cortex (BNT), we observed a partial normalization of brain activity and connectivity within the BG and the sensorimotor network. Although BNT treatment did not influence the loss of responsiveness within the putamen and the thalamus (which might be associated with the concept of the loss of inhibition in CD) in a detectable manner, it had decreased their overall output. It is arguable that BNT treatment will be an essential tool for dissociating effects from cause in CD in future studies.
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[^1]: Seventeen patients with cervical dystonia (CD, mean age ± SD = 61.3 ± 10.5 years; nine females) and 17 age-matched controls (mean age ± SD = 63.5 ± 10.5 years; 8 female) participated in this study. MMSE: Mini-Mental Statu Examination.

[^2]: All patients with CD underwent treatment with BNT (6 months, 3 total applications), and clinical severity was measured using the TWSTRS (Toronto Western Spasmodic Torticollis Rating Scale). The TWSTRS score decreased from mean of 23 to a mean of 14 after the administration of BNT. The nonparametric signed-rank test (Wilcoxon) revealed a significant group difference at *p* ≤ 0.001 (Z = −3.633).

[^3]: We included the primary and secondary somatosensory cortex (S1 and S2) and the primary motor cortex (M1) along with the BG and the thalamus. The table provides the final size of each ROI in voxels within the coregistered and normalized structural T1 image. MNI coordinates are given for the left and right hemispheres of each ROI.
